High incidence of morphological myelodysplasia and apoptotic bone marrow cells in Behçet's disease

Journal of Clinical Immunology

Volumn 27, Issue 2, 2007, Pages 145-151

  Arimura, Kosei ^a   Arima, Naomichi ^b   Matsushita, Kakushi ^a   Akimoto, Masaki ^a   Park, Chi Young ^a   Uozumi, Kimiharu ^b   Tei, Chuwa ^b  

^a KAGOSHIMA UNIVERSITY HOSPITAL   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Beh et's disease; Bone marrow cells; In situ end labeling method; Morphological myelodysplasia; Myelodysplastic syndrome

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; BEHCET DISEASE; BONE MARROW CELL; CELL DEATH; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPENIA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; INFLAMMATORY DISEASE; MALE; MYELODYSPLASIA; PRIORITY JOURNAL;

ADULT; AGED; APOPTOSIS; BEHCET SYNDROME; BONE MARROW CELLS; FEMALE; HLA-B ANTIGENS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES;

EID: 33847407937     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-006-9064-9     Document Type: Article

References (18)

1. International Study Group for Behçet's disease. Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080, 1990
2. Ohno E, Ohtsuka E, Watanabe K, Kohno T, Takaoka K, Saburi Y, Kikuchi H, Nasu M. Behçet's disease associated with myelodysplastic syndromes. Cancer 79:262-268, 1997
3. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet's disease. N Engl J Med 341:1284-1291, 1999
4. Gul A. Behcet's disease: An update on the pathogenesis. Clin Exp Rheumatol 19:S6-S12, 2001
5. Rotteveel FT, Kokkelink I, van Lier RA, Kuenen B, Meager A, Miedema F, Lucas CJ. Clonal analysis of functionally distinct human CD4+ T cell subsets. J Exp Med 168:1659-1673, 1988
6. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51:189-199, 1982
7. Clark DM, Lampert IA. Apoptosis is a common histopathological finding in myelodysplasia: The correlate of ineffective hematopoiesis. Leuk Lymphoma 2:415-418, 1990
8. Arimura K, Arima N, Matsushita K, Ohtsubo H, Fujiwara H, Kukita T, Ozaki A, Hagiwara T, Hamada H, Yoshino K, Tei C. Matrix metalloproteinase inhibitor reduces apoptosis induction of bone marrow cells in MDS-RA. Eur J Haematol 73:17-24, 2004
9. Karuvannur S, Lipstein E, Brennessel D, Rosner F. Atypical Behçet's syndrome in a patient with myelodysplastic syndrome. Mount Sinai J Med 68:403-405, 2001
10. Oh EJ, Yoon JS, Park YJ, Cho CS, Kim BK. Behçet's disease associated with myelodysplastic syndrome. JKorean Med Sci 14:685-687, 1999
11. Behçet's Disease Research Committee of Japan. Criteria for diagnosis of Behçet's disease. In Annual Report of Behçet's Disease, Y Mizushima, ed. Tokyo, Research Committee of Japan, Ministry of Health and Welfare of Japan, 1986
12. Imamura Y, Kurokawa MS, Yoshikawa H, Nara K, Takada E, Masuda C, Tsukikawa S, Ozaki S, Matsuda T, Suzuki N. Involvement of Th1 cells and heat shock protein 60 in the pathogenesis of intestinal Behcet's disease. Clin Exp Immunol 139:371-378, 2005
13. Koarada S, Haruta Y, Tada Y, Ushiyama O, Morito F, Ohta1 A, Nagasawa K. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behçet's disease. Rheumatology 43:843-851, 2004
14. Nagafuchi H, Takeno M, Yoshikawa H, Kurokawa MS, Nara K, Takada E, Masuda C, Mizoguchi M, Suzuki N. Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behçet's disease. Clin Exp Immunol 139:363-370, 2004
15. Sloand EM, Mainwaring L, Fuhrer M, Ramkissoon S, Risitano AM, Keyvanafar K, Lu J, Basu A, Barrett AJ, Young NS. Preferential suppression of trisomy 8 versus normal hematopoietic cell growth by autologous lymphocytes in patients with trisomy 8 myelodysplastic syndrome. Blood 106:841-851, 2005
16. Niwa Y, Miyake S, Sakane T, Shingu M, Yokoyama M. Autooxidative damage in Behçet's disease - endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. Clin Exp Immunol 49:247-255, 1982
17. Yano K, Eguchi K, Migita K, Takashima H, Tamura M, Izumino K, Sasagawa I, Sadamori N, Nagataki S. Behçet's disease complicated with myelodysplastic syndrome: A report of two cases and review of the literature. Clin Rheumatol 15:91-93, 1996
18. Turan B, Gallati H, Erdi H, Gurler A, Michel BA, Villiger PM. Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Behçet's disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol 24:128-132, 1997